Skip to content

Hypophosphatemic Rickets in Norway

Hypophosphatemic Rickets in Norway

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01057186
Enrollment
80
Registered
2010-01-27
Start date
2009-12-31
Completion date
Unknown
Last updated
2016-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypophosphatemia, Familial, Rickets, Hyperphosphatemia

Brief summary

The purpose of the study is to do a follow-up survey of all individuals with hereditary hypophosphatemia in Norway, focusing on manifestations in childhood and adolescence. The investigators also want to study phenotype-genotype associations, and look for new genes, in all forms of hereditary hypo and hyperphosphatemia.

Interventions

DIETARY_SUPPLEMENTAlfacalcidol; phosphate.

Individual dosage form and dosage depending on phenotype and underlying cause.

Pills. Individual dosage depending on clinical symptoms/phenotype.

Sponsors

Haukeland University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* All patients in the Norwegian population with hereditary hypophosphatemia, with or without rickets * Patients in the Norwegian population with hereditary hyperphosphatemia

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
GrowthUp to 18 yearsChange i height z-score from time of diagnosis to last registered consultation.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026